Stoliker, Devon https://orcid.org/0000-0001-6724-4497
Novelli, Leonardo
Khajehnejad, Moein
Biabani, Mana
Greaves, Matthew D.
Barta, Tamrin
Williams, Martin https://orcid.org/0000-0002-9483-3008
Chopra, Sidhant https://orcid.org/0000-0003-0866-3477
Bazin, Olivier
Simonsson, Otto https://orcid.org/0000-0003-4197-7566
Chambers, Richard
Barrett, Frederick S. https://orcid.org/0000-0001-7443-3237
Deco, Gustavo https://orcid.org/0000-0002-8995-7583
Preller, Katrin H. https://orcid.org/0000-0003-0413-7672
Carhart-Harris, Robin L. https://orcid.org/0000-0002-6062-7150
Seth, Anil K. https://orcid.org/0000-0002-1421-6051
Sundram, Suresh
Egan, Gary F.
Razi, Adeel https://orcid.org/0000-0002-0779-9439
Article History
Received: 13 April 2025
Accepted: 14 July 2026
First Online: 19 August 2026
Ethics
Competing interests: F.S.B. is an advisor and shareholder at Mindstate Design Labs; and is a scientific advisor for Wavepaths and Lilly USA. O.S. was previously a co-founder of Eudelics, but currently has no financial relationship with the company; and is a co-founder of embla.ai. R.C. was previously a co-founder of Eudelics, but currently has no association with, or financial interest in, the company; provides executive coaching and organisational consulting through a private business that may incorporate mindfulness-based approaches. K.H.P. is an employee of Boehringer Ingelheim; serves as Chief Scientist of the Board of Directors of the Heffter Research Institute; and is a scientific advisor to the Mind Foundation. R.L.C.-H. is a scientific advisor to TRYP therapeutics, Osmind, Mindstate Design Labs, Otsuka and Red Light Holland. A.K.S. is an advisor to Conscium and AllJoined. The other authors declare no competing interests.